The Asia-Pacific medical device contract manufacturing market, valued at USD 17.3 billion in 2025, is projected to reach USD 18.9 billion in 2026 and USD 38.1 billion by 2035, with a CAGR of 8.1% during the forecast period from 2026 to 2035. The region includes a growing network of contract manufacturers serving complex medical device categories, including minimally invasive devices, diagnostic equipment, cardiovascular products, orthopedic implants, diabetes care solutions, wearable medical dev...

The global insulin pump market, valued at USD 6.1 billion in 2025, is projected to reach USD 6.5 billion in 2026 and USD 13.6 billion by 2035, representing a CAGR of 8.5% during the forecast period 2026 to 2035. In terms of type of pump, the patch pumps segment holds the highest (more than 60%) share of the current market. The emergence of automated insulin delivery systems represents a defining shift in the domain. These platforms use real-time glucose data and algorithms to adjust insulin deli...

The North America medical device contract manufacturing market, valued at USD 40.9 billion in 2025, is projected to reach USD 43.9 billion in 2026 and USD 75.5 billion by 2035, with a CAGR of 6.2% during the forecast period 2026 to 2035. North America represents the largest and most advanced market for medical device contract manufacturing, driven by its robust medtech ecosystem and strong culture of innovation. The US, in particular, continues to generate significant demand for contract manufac...

The global exoskeleton market, valued at USD 2.9 billion in 2025, is projected to reach USD 3.7 billion in 2026 and USD 20.3 billion by 2035, representing a CAGR of 20.8% during the forecast period 2026 to 2035. The exoskeleton market is gaining relevance as mobility impairment becomes a larger clinical, social, and economic burden. Neurological conditions are now among the leading causes of disability worldwide; in 2025, the World Health Organization reported that neurological conditions affect...

The global large volume wearable injectors market, valued at USD 12.6 billion in 2025, is projected to reach USD 16.4 billion in 2026 and USD 31.4 billion by 2035, representing a CAGR of 7.5% during the forecast period 2026 to 2035. The market numbers have been calculated by taking into account the revenues generated through sales of large volume wearable injectors and related drug-device combination products. Based on market share distribution by therapeutic area, devices used to treat autoimmu...

The wearable injectors market, valued at USD 6.5 billion in 2025, is projected to reach USD 6.8 billion in 2026 and USD 13.0 billion by 2035, representing a CAGR of 7.4% during the forecast period 2026 to 2035. Please note that the total wearable injectors market includes the sum of both insulin and non insulin drugs market. In terms of type of device, currently, the infusion pumps hold the highest share (more than 90%) of the insulin pumps market. The global surge in chronic disorders, such as...

The global next generation contact lenses and visual prostheses market, valued at USD 0.36 billion in 2024, is projected to reach USD 0.60 billion in 2025 and USD 16.97 billion by 2035, representing a CAGR of 39.7% during the forecast period. It is worth highlighting here that there is a rapid increase witnessed in the number of blind and partially sighted individuals. According to the National Eye Institute, nearly 1.3 million people are blind, while 2.9 million individuals have poor vision, in...

The global surgical robots market, valued at USD 9.8 billion in 2025, is projected to reach USD 10.6 billion in 2026 and USD 22.9 billion by 2035, with a 8.9% CAGR during the forecast period 2026 to 2035. In terms of geography, North America captures the majority of the market share.

The ultrasound market is estimated to grow from USD 9.6 billion in 2025 to reach USD 10.2 billion in 2026 and USD 16.0 billion by 2035, representing a CAGR of 5.1% during the forecast period. In May 2026, ClearPoint Neuro entered into a collaboration with Sungkyunkwan University to expand its drug delivery ecosystem. The collaboration follows successful preclinical trials demonstrating ultrasound-enabled delivery across the blood-brain barrier, aiming to accelerate commercialization and global e...

The global pulsed field ablation market, valued at USD 2.3 billion in 2025, is projected to reach USD 3.2 billion in 2026 and USD 14.6 billion by 2035, representing a CAGR of 18.4% during the forecast period 2026 to 2035. Clinical and preclinical research continues to expand the PFA evidence base, with multiple energy-delivery systems and procedural workflows under investigation. For instance, Boston Scientific’s FARAPULSE™ pulsed-field ablation (PFA) system demonstrated symptomatic relief i...

The global prefilled syringes market, valued at USD 3,818 million in 2025, is projected to reach USD 4,122 million in 2026 and USD 6,750 million by 2035, representing a CAGR of 5.6% during the forecast period 2026 to 2035. In terms of therapeutic area, the market for hematological disorders is likely to capture the highest share (more than 65%) of the global prefilled syringes industry in 2026 due to the high volume of anticoagulants and blood stimulants standardized for delivery via prefilled f...

The global drug reconstitution systems market, valued at USD 5.4 billion in 2025, is projected to reach USD 5.9 billion in 2026 and USD 10.8 billion by 2035, representing a CAGR of 7.0% during the forecast period 2026 to 2035. In terms of type of reconstitution system, cartridges hold the highest share (close to 50%) of the current market. Based on fabrication material, the glass segment holds the largest share of the current market.

The global medication adherence market, valued at USD 5.45 billion in 2025, is projected to reach USD 6.08 billion in 2026 and USD 15.35 billion by 2035, representing a CAGR of 10.92% during the forecast period 2026 to 2035. In May 2026, Omnicell, a leading healthcare technology provider focused on empowering autonomous medication management, announced its participation at the BofA Securities 2026 Healthcare Conference. In January 2026, MIT engineers developed ingestible pills equipped with biod...

The global infusion pumps market size is valued at USD 13.90 billion in 2025 and projected to grow from USD 14.87 billion 2026 to USD 25.39 billion in 2035, representing a CAGR of 6.1% during the forecast period 2026 to 2035. In terms of device type, volumetric pumps currently hold the largest share (30%) due to their high precision, safety, versatility, and broad applications in healthcare (including blood infusion, drug administration, fluid transmission during surgeries, nutrient delivery). A...

The global atrial fibrillation treatment devices market, valued at USD 7.9 billion in 2025, is projected to reach USD 9.6 billion in 2026 and USD 29.0 billion by 2035, representing a CAGR of 13.1% during the forecast period 2026 to 2035. Atrial fibrillation currently affects tens of millions of individuals worldwide, with global prevalence estimates exceeding 50 million cases. Driven by the aging populations and growing prevalence of hypertension, obesity, diabetes, and unhealthy lifestyles, the...

The global cancer biomarkers market, valued at USD 24.5 billion in 2025, is projected to reach USD 25.9 billion in 2026 and USD 37.8 billion by 2035, representing a CAGR of 4.3% during the forecast period 2026 to 2035. In December 2025, Lunit partnered with Daiichi Sankyo to accelerate biomarker discovery and optimize translational research by integrating its multiple AI-powered Lunit SCOPE digital pathology products across its two oncology pipeline programs.  In July 2025, Tianfu Wu (an associ...

The global autoinjectors market is estimated to grow from USD 170 billion in 2025 to reach USD 181 billion in 2026 and USD 299 billion by 2035, representing a higher CAGR of 5.7% during the forecast period. In February 2026, Eco-Inject secured £5.2 million in equity funding to scale low carbon, next generation autoinjectors, increase production capacity, meet regulatory requirements, and expand into the global autoinjector market. In November 2025, SHL Medical announced that it has achieved a...

The global dual chamber devices market, valued at USD 5.81 billion in 2025, is likely to reach USD 6.25 billion in 2026 and USD 17.56 billion by 2040, representing a CAGR of 7.7% during the forecast period. Based on the material of fabrication, glass is likely to capture more than 90% of the overall dual chamber devices for prefilled syringes market share in 2026. This is because of the inherently sterile and inert nature of glass with great barrier properties. Based on volume of container, >1ml...

The global medical device contract manufacturing market size, valued at USD 92.6 billion in 2025, is projected to reach USD 99.8 billion in 2026 and USD 181.4 billion by 2035, with a CAGR of 6.9% during the forecast period 2026 to 2035. This market is growing steadily, driven by continuous technological advancements, leading to the development of complex and innovative medical devices. This has prompted the medical device companies to seek specialized services from medical device contract manufa...

The global virtual ward market is expected to rise from USD 3.10 billion in 2026 to reach USD 17.80 billion by 2040, growing at a CAGR of 13.3% over the forecast period 2026 to 2040, driven by hospital capacity pressure, remote monitoring maturity, and payer support for hospital-at-home models. Based on geography, North America captures 41.4% market share in 2026, whereas Asia-Pacific registers a 15.6% CAGR through 2040, driven by digitalization and hospital-capacity localization. Integration bu...